These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2317558)

  • 21. Intact microtubules are necessary for complete processing, storage and regulated secretion of von Willebrand factor by endothelial cells.
    Sinha S; Wagner DD
    Eur J Cell Biol; 1987 Jun; 43(3):377-83. PubMed ID: 3305020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of intracellular storage and regulated secretion of 3 von Willebrand disease-causing variants of von Willebrand factor.
    Michaux G; Hewlett LJ; Messenger SL; Goodeve AC; Peake IR; Daly ME; Cutler DF
    Blood; 2003 Oct; 102(7):2452-8. PubMed ID: 12791651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differing polarity of the constitutive and regulated secretory pathways for von Willebrand factor in endothelial cells.
    Sporn LA; Marder VJ; Wagner DD
    J Cell Biol; 1989 Apr; 108(4):1283-9. PubMed ID: 2494192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative response of plasma VWF in dogs to up-regulation of VWF mRNA by interleukin-11 versus Weibel-Palade body release by desmopressin (DDAVP).
    Olsen EH; McCain AS; Merricks EP; Fischer TH; Dillon IM; Raymer RA; Bellinger DA; Fahs SA; Montgomery RR; Keith JC; Schaub RG; Nichols TC
    Blood; 2003 Jul; 102(2):436-41. PubMed ID: 12649145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor.
    Eikenboom JC; Matsushita T; Reitsma PH; Tuley EA; Castaman G; Briët E; Sadler JE
    Blood; 1996 Oct; 88(7):2433-41. PubMed ID: 8839833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. von Willebrand factor propeptide missense variants affect anterograde transport to Golgi resulting in ER retention.
    Yadegari H; Biswas A; Ahmed S; Naz A; Oldenburg J
    Hum Mutat; 2021 Jun; 42(6):731-744. PubMed ID: 33942438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Von Willebrand disease and Weibel-Palade bodies.
    Wang JW; Eikenboom J
    Hamostaseologie; 2010 Aug; 30(3):150-5. PubMed ID: 20680229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoelectron microscopic localization of factor VIII-related antigen in the vascular endothelial cells of a patient with type 1 von Willebrand disease.
    Imuta M
    J Electron Microsc (Tokyo); 1998; 47(2):175-7. PubMed ID: 9723159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rickettsia rickettsii infection of cultured endothelial cells induces release of large von Willebrand factor multimers from Weibel-Palade bodies.
    Sporn LA; Shi RJ; Lawrence SO; Silverman DJ; Marder VJ
    Blood; 1991 Nov; 78(10):2595-602. PubMed ID: 1824255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dispatch and delivery at the ER-Golgi interface: how endothelial cells tune their hemostatic response.
    Kat M; Margadant C; Voorberg J; Bierings R
    FEBS J; 2022 Nov; 289(22):6863-6870. PubMed ID: 35246944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polar secretion of von Willebrand factor by endothelial cells.
    van Buul-Wortelboer MF; Brinkman HJ; Reinders JH; van Aken WG; van Mourik JA
    Biochim Biophys Acta; 1989 May; 1011(2-3):129-33. PubMed ID: 2785404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the storage and secretion of von Willebrand factor in blood outgrowth endothelial cells derived from patients with von Willebrand disease.
    Wang JW; Bouwens EA; Pintao MC; Voorberg J; Safdar H; Valentijn KM; de Boer HC; Mertens K; Reitsma PH; Eikenboom J
    Blood; 2013 Apr; 121(14):2762-72. PubMed ID: 23426949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Mechanistic Model to Quantify von Willebrand Factor Release, Survival and Proteolysis in Patients with von Willebrand Disease.
    Ferrari M; Galvanin F; Barolo M; Daidone V; Padrini R; Bezzo F; Casonato A
    Thromb Haemost; 2018 Feb; 118(2):309-319. PubMed ID: 29378356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dominant p.Thr274Pro mutation in the von Willebrand factor propeptide causes the von Willebrand disease type 1 phenotype in two unrelated patients.
    Pagliari MT; Baronciani L; Cordiglieri C; Colpani P; Cozzi G; Siboni SM; Peyvandi F
    Haemophilia; 2022 Mar; 28(2):292-300. PubMed ID: 35064738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of cysteine 584 impairs the storage and release, but not the synthesis of von Willebrand factor.
    Daidone V; Barbon G; Pontara E; Cattini GM; Gallinaro L; Zampese E; Pizzo P; Casonato A
    Thromb Haemost; 2014 Dec; 112(6):1159-66. PubMed ID: 25230768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Weibel-Palade bodies: a window to von Willebrand disease.
    Valentijn KM; Eikenboom J
    J Thromb Haemost; 2013 Apr; 11(4):581-92. PubMed ID: 23398618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel case of compound heterozygosity with "Normandy"/type I von Willebrand disease (vWD). Direct demonstration of the segregation of one allele with a defective expression at the mRNA level causing type I vWD.
    Siguret V; Lavergne JM; Chérel G; Boyer-Neumann C; Ribba AS; Bahnak BR; Meyer D; Piétu G
    Hum Genet; 1994 Feb; 93(2):95-102. PubMed ID: 7906671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiogenic characteristics of blood outgrowth endothelial cells from patients with von Willebrand disease.
    Groeneveld DJ; van Bekkum T; Dirven RJ; Wang JW; Voorberg J; Reitsma PH; Eikenboom J
    J Thromb Haemost; 2015 Oct; 13(10):1854-66. PubMed ID: 26270243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. von Willebrand disease and von Willebrand factor.
    Sadler B; Castaman G; O'Donnell JS
    Haemophilia; 2022 May; 28 Suppl 4(Suppl 4):11-17. PubMed ID: 35521725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.